Brooke Raphael
Non-Executive Director

Brooke brings over 20 years of experience across clinical development, regulatory affairs, and commercialisation in the biopharmaceutical and life sciences sectors. Her career spans roles at the intersection of strategy, operations, and capital markets, with a strong focus on supporting innovative healthcare companies through critical growth stages.

She currently serves as Partner and Chief Operating Officer at Avicella Capital, a US-based healthcare-focused venture capital fund, where she works closely with early-stage biotechnology and healthcare ventures to guide strategic development and investment pathways.

Brooke’s combined experience in venture capital, clinical development, and strategic leadership will be invaluable as we continue to advance our pipeline of therapies with transdiagnostic potential—designed to restore social behaviour and treat related symptoms across many diseases and disorders.